786 results on '"Tazuma, Susumu"'
Search Results
52. Comparing the Acid-Suppressive Effects of Three Brands of Generic Lansoprazole with the Original: Pharmacokinetic Bioequivalence Tests Do Not Necessarily Guarantee Pharmacodynamic Equivalence
53. Partial characterization of proapoptotic action of biliary deteriorated lipids on biliary epithelial cells in pancreaticobiliary diseases
54. Clinical efficacy of intravenous ciprofloxacin in patients with biliary tract infection: a randomized controlled trial with carbapenem as comparator
55. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan
56. Recent understanding of cholesterol gallstone pathogenesis: implication to non-surgical therapeutic strategy
57. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells
58. Donor age (≥45 years) and reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation – a multicenter retrospective study
59. Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020
60. Retrospective cohort study of the incidence and risk of fever in elderly people living at home: A pragmatic aspect of home medical management in Japan
61. Acid-Suppressive Effects of Various Regimens of Omeprazole in Helicobacter pylori-Negative CYP2C19 Homozygous Extensive Metabolizers: Which Regimen Has the Strongest Effect?
62. Which Has Superior Acid-Suppressive Effect, 10 Mg Omeprazole Once Daily or 20 Mg Famotidine Twice Daily? Effects of Single or Repeated Administration in Japanese Helicobacter Pylori-Negative CYP2C19 Extensive Metabolizers
63. Lafutidine, a Newly Developed Antiulcer Drug, Elevates Postprandial Intragastric pH and Increases Plasma Calcitonin Gene-Related Peptide and Somatostatin Concentrations in Humans: Comparisons with Famotidine
64. Acid-Suppressive Efficacy of a Reduced Dosage of Rabeprazole: Comparison of 10 Mg Twice Daily Rabeprazole with 20 Mg Twice Daily Rabeprazole, 30 Mg Twice Daily Lansoprazole, and 20 Mg Twice Daily Omeprazole by 24-Hr Intragastric pH-metry
65. Hepatitis C Virus Core Protein Modulates Fatty Acid Metabolism and Thereby Causes Lipid Accumulation in the Liver
66. Angiotensin II Participates in Hepatic Inflammation and Fibrosis through MCP-1 Expression
67. A Nuclear Receptor Ligand Down-Regulates Cytosolic Phospholipase A 2 Expression to Reduce Bile Acid–Induced Cyclooxygenase 2 Activity in Cholangiocytes: Implications of Anticarcinogenic Action of Farnesoid X Receptor Agonists
68. Partial characterization of cytoprotective mechanisms of lecithin against bile salt-induced bile duct damage
69. Gastric Acid Normosecretion Is Not Essential in the Pathogenesis of Mild Erosive Gastroesophageal Reflux Disease in Relation to Helicobacter pylori Status
70. Unique Inhibition of Bile Salt-Induced Apoptosis by Lecithins and Cytoprotective Bile Salts in Immortalized Mouse Cholangiocytes
71. A CASE OF PARANEOPLASTIC SYNDROME MIMICKING ADULT STILLʼS DISEASE CAUSED BY RECTAL CANCER
72. Dietary intervention for adult survivors of cancers other than breast cancer: A systematic review.
73. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse
74. Phospholipid Alterations in Hepatocyte Membranes and Transporter Protein Changes in Cholestatic Rat Model
75. Bile Acid Reflux and Possible Inhibition of Helicobacter pylori Infection in Subjects Without Gastric Surgery
76. Modifying Hepatic Phospholipid Synthesis Associates with Biliary Phospholipid Secretion Rate in a Transporter-Independent Manner in Rats
77. Dose-Dependent Conjugation of Sulfobromophthalein and Hepatic Transit Time in Bile Fistula Rats
78. Carcinogenesis of malignant lesions of the gall bladder: The impact of chronic inflammation and gallstones
79. Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)
80. Gallbladder Dysfunction Enhances Physical Density But Not Biochemical Metastability of Biliary Vesicles
81. Role of Phospholipase A2 in Cholesterol Gallstone Formation Is Associated with Biliary Phospholipid Species Selection at the Site of Hepatic Excretion
82. Bilirubin overload modulates bile canalicular membrane fluidity in rats: association with disproportionate reduction of biliary lipid secretion
83. Spontaneously hypertensive rats develop pronounced hepatic steatosis induced by choline-deficient diet: Evidence for hypertension as a potential enhancer in non-alcoholic steatohepatitis
84. Transcytotic Vesicle Fusion Is Reduced in Cholestatic Rats (Redistribution of Phospholipids in the Canalicular Membrane)
85. Partial Characterization of Mechanisms of Cytoprotective Action of Hydrophilic Bile Salts Against Hydrophobic Bile Salts in Rats (Relation to Canalicular Membrane Fluidity and Packing Density)
86. Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study
87. Clinical efficacy of i.v. doripenem, a new class of carbapenem, in patients with biliary tract infection: A multicenter trial
88. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non‐alcoholic steatohepatitis
89. Erythromelalgic Symptoms in Left Subclavian Artery Stenosis
90. 6. Pitfall in Outpatient Care at General Internal Medicine
91. Lactobacillus plantarum SN13T Cells Improve Hepatic Dysfunction And Fecal Microbiota: A Randomized Pilot Study
92. A case of giant cell arteritis simultaneously diagnosed with chronic subdural hematoma
93. Decrease in major secondary bile acid, hyodeoxycholic acid, was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model
94. Protective effect of phosphatidylcholine on lysophosphatidylcholine‐induced cellular senescence in cholangiocyte
95. Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study
96. Geographical distribution of family physicians in Japan: A nationwide cross-sectional study
97. Bile Salt Hydrophobicity Modulates Subselection of Biliary Lecithin Species in Rats Depleted of Bile Salt Pool
98. Extracellular and Intracellular Regulation of Biliary Lecithin Hydrophobicity
99. Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage
100. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.